"To complete the application, the agency noted that an inspection of the manufacturing facility is required as a part of the standard revie...

Biocon and Mylan’s proposed biosimilar bevacizumab, a cancer drug, is expected to be the third biosimilar from the partnered portfolio for ...

The launch of Versavo is another step in that journey and helps in strengthening the company's oncology portfolio.

Biosimilar drugs are the follow on versions of biologic drugs which are composed of sugars, proteins, nucleic acids or complex combinations...

The ministry expects the final guidelines to uphold the safety and efficacy of biosimilar drugs hitting the Indian market through stringent...

In 2014, Reliance had entered into a similar arrangement with Torrent Pharma to sell copies of three drugs -- rituximab, adalimumab and cet...

Roche, which invented the drug and markets it under the blockbuster brand ‘Avastin’, has argued that Hetero’s drug is not a biosimilar to b...

The judge asked the company to submit a compilation of judgments highlighting the protection given to drug innovators to support its call.

Roche has challenged the regulator and pleaded to block the approvals of the drugs under review, ET learned from highly placed legal source...

The Drug Controller General of India has passed an order removing an alert notice for the use of Roche’s Avastin (bevacizumab) injection to...

Roche has initiated an internal investigation following reports the it had been used in certain eye ailments and damaged the vision of 15 p...

Strides Arcolab has invested in Oncobiologics Inc, a privately held US-based drug company focussed on biosimilar and novel biologic drug re...

Cipla, the Indian drugmaker that built a $1-billion business making generic HIV treatments, aims to sell copies of Roche Holding's and Amge...

Swiss pharmaceutical giant Roche said it has completed its $46.8 billion takeover of California-based biotech firm Genentech.

Genentech Inc. says its shareholders should reject a hostile buyout bid from Swiss drugmaker Roche.

Roche Holding AG lowered the acquisition price by 2.8% and took the offer for the US cancer-drug developer directly to shareholders.

Swiss drugmaker Roche has filed its Avastin drug for use in previously untreated advanced breast cancer in Europe, the company said on Mond...